Showing results (201-210 of 275) with videos related to

Sort By:
Pageof 28
JAMA|March 4, 1992
Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. Italian Zidovudine Evaluation GroupS Vella, M Giuliano, P Pezzotti, et al.
Blood|July 1, 1996
Kaposi's sarcoma (KS)-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: association with KS and persistence in patients receiving anti-herpesvirus drugsR W Humphrey, T R O'Brien, F M Newcomb, et al.
Blood|September 26, 2000
An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virusC B Foster, T Lehrnbecher, S Samuels, et al.
Lancet (London, England)|March 15, 1986
Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complexR Yarchoan, R W Klecker, K J Weinhold, et al.
The Journal of Infectious Diseases|September 9, 1999
Longitudinal human immunodeficiency virus type 1 load in the italian seroconversion study: correlates and temporal trends of virus loadC M Lyles, M Dorrucci, D Vlahov, et al.
The West Indian Medical Journal|April 14, 2015
A Simplified HAART Regimen with Raltegravir and Lamivudine, and Pharmacokinetic Interactions with a Combined Immunosuppressive Therapy with Tacrolimus and Everolimus in an HIV/HCV/HBV/HDV Patient after Liver TransplantationO Cirioni, L E Weimer, V Fragola, et al.
BMJ (Clinical Research Ed.)|April 23, 1994
Survival differences in European patients with AIDS, 1979-89. The AIDS in Europe Study GroupJ D Lundgren, C Pedersen, N Clumeck, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1994
Long-term follow-up of zidovudine therapy in asymptomatic HIV infection: results of a multicenter cohort study. The Italian Zidovudine Evaluation GroupS Vella, M Giuliano, L G Dally, et al.
Blood|March 25, 2000
Variant genotypes of FcgammaRIIIA influence the development of Kaposi's sarcoma in HIV-infected menT L Lehrnbecher, C B Foster, S Zhu, et al.
Antiviral Research|May 13, 1999
A phase I trial of the pharmacokinetics, toxicity, and activity of KNI-272, an inhibitor of HIV-1 protease, in patients with AIDS or symptomatic HIV infectionR W Humphrey, K M Wyvill, B Y Nguyen, et al.
Pageof 28